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It has previously been shown that carbapenem-resistant Acinetobacter baumannii
are frequently detected in Saudi Arabia. The present study aimed to identify the
epidemiology and distribution of antibiotic resistance determinants in these bacteria.
A total of 83 A. baumannii isolates were typed by pulsed-field gel electrophoresis
(PFGE), and screened by PCR for carbapenemase genes and insertion sequences.
Antibiotic sensitivity to imipenem, meropenem, tigecycline, and colistin were determined.
Eight different PFGE groups were identified, and were spread across multiple hospitals.
Many of the PFGE groups contained isolates belonging to World-wide clone 2.
Carbapenem resistance or intermediate resistance was detected in 69% of isolates.
The blaVIM gene was detected in 94% of isolates, while blaOXA 23 like genes were
detected in 58%. The data demonstrate the co-existence and wide distribution
of a number of clones of carbapenem-resistant A. baumannii carrying multiple
carbapenem-resistance determinants within hospitals in the Eastern Region of Saudi
Arabia.
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Introduction
A number of recent studies have identified high levels of carbapenem resistance in isolates of
Acinetobacter baumannii from Saudi Arabia (Alsultan et al., 2013; Abdalhamid et al., 2014; Aly et al.,
2014). These studies have demonstrated that a large number of different genetic lineages within
a hospital are resistant to the carbapenems, rather than there being the predominance of a single
epidemic clone (Abdalhamid et al., 2014; Aly et al., 2014). These isolates often belong to widespread
clonal lineages (Zarrilli et al., 2013). However, due to examining only isolates obtained from a
single hospital (Abdalhamid et al., 2014; Aly et al., 2014), or the absence of molecular typing data
(Alsultan et al., 2013), it is still not clear what the epidemiological pattern of carbapenem-resistant
A. baumannii is on a wider scale within Saudi Arabia.
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It was previously shown in a study utilizing relatively few
isolates that a number of different lineages of A. baumannii,
defined by pulsed-field gel electrophoresis (PFGE), were
associated with infections in diabetic patients in Saudi Arabia,
with one of these lineages found in more than one hospital
(Alsultan et al., 2009). A much larger study found that isolates
from diabetic patients were more likely to be carbapenem
resistant and carry an acquired OXA-type b-lactamase, but did
not identify the molecular epidemiology of the isolates (Alsultan
et al., 2013). A recent study carried out in AbuDhabi, United Arab
Emirates, that borders Saudi Arabia, identified a diverse range
of isolates, with even the epidemic isolates belonging to multiple
PFGE pulsotypes and genotypes (Sonnevend et al., 2013).
The high and increasing prevalence of type 2 diabetes is a very
serious health concern in Saudi Arabia, and as these patients are
particularly susceptible to bacterial infection, the prevalence of
carbapenem-resistant A. baumannii in this group is of particular
concern (Prata-Rocha et al., 2012). Here we have typed a larger
collection of 83 A. baumannii isolates taken from a combination
of diabetic and non-diabetic patients from the Eastern District
of Saudi Arabia. We aim to determine the epidemiological
relationships between isolates and the distribution of antibiotic
resistance determinants in this bacterial population, in order
to address the lack of molecular epidemiological data between
hospitals in a wider geographic context.
Materials and Methods
A total of 83 isolates were collected between 2008 and 2012
from different specimens from patients from 7 major hospitals in
the Eastern province of Saudi Arabia—23 isolates from patients
with type 2 Diabetes Mellitus, and 60 isolates from patients
without this condition. For the purpose of our study, patients
were considered to be diabetic if they were using insulin and were
undergoing hospital treatment for the condition. All isolates were
identified presumptively by the Vitek compact II system as being
A. baumannii.
Multiplex polymerase chain reactions (PCRs) using primers
for the blaOXA 51 like, blaOXA 23 like, blaOXA 40 like, and
blaOXA 58 like genes were performed (Woodford et al., 2006),
with species identification being confirmed by the production
of a blaOXA 51 like amplicon. Amplification and sequencing of
complete blaOXA 51 like alleles was performed using the primers
OXA-69A and OXA-69B (Heritier et al., 2005), and the allele
identity used to determine the epidemic lineage to which the
isolate belonged as first described by Evans et al. (2008) and
later confirmed by Pournaras et al. (2014). Isolates were screened
by PCR for the presence of acquired metallo-b-lactamase
genes (MBLs) of the blaIMP, blaVIM, blaNDM, blaSIM, and blaGIM
(Ellington et al., 2007; Poirel et al., 2011) families using consensus
primers, and for the insertion sequences ISAba1, ISAba2, ISAba3,
and IS18 (Poirel and Nordmann, 2006).
The minimum inhibitory concentrations (MICs) of imipenem,
meropenem, tigecycline and colistin were determined by the agar
plate doubling-dilution method according to the British Society
for Antimicrobial Chemotherapy (BSAC) guidelines (Andrews,
2010).
Isolates were typed by PFGE using the method described by
Miranda et al. (1996) as previously described (Evans et al., 2008).
PFGE profiles were analyzed using the Bionumerics software
version 6.5. All data were analyzed in SPSS version 20 (SPSS Inc.,).
Following Kruskal Wallis tests, differences between groups were
determined by pairwise Mann-Whitney U tests. Correction for
multiple testing was performed using the method of Benjamini
and Hochberg (1995).
Results
Isolates were grouped according to their PFGE profiles (Figure 1).
Sixty-two isolates were assigned to one of eight different PFGE
groups, defined as having PFGE profiles with 85% similarity or
greater, and consisting of at least three isolates. The remaining
21 isolates that did not meet these criteria were considered to
be ungrouped. There was a significant difference in the diabetic
status of the patients between the individual PFGE groups
(Kruskal Wallis, $2 = 26.32, d.f. = 7, p = 0.0024 following
correction), with isolates from diabetic patients being in the
majority in PFGE groups B, D, and H (Figure 1).
The majority of the isolates (67%) were from Al Ahsa, with
most of the remaining isolates (24%) originating from Al Qatif.
In Al Ahsa, isolates representing all eight of the PFGE groups
were identified (Figure 2). Three of these groups were also
identified in Al Qatif. Additionally, isolates from one or more
of the PFGE groups were identified at the five other locations
sampled, despite the geographic distance between these hospitals
(Figure 2).
Of the 83 isolates, 57 (69%) were resistant or had intermediate
resistance to at least one carbapenem. In agreement with previous
findings (Alsultan et al., 2013), isolates fromdiabetic patients were
more likely to be resistant to a carbapenem than those from non-
diabetic patients (diabetic status vsmeropenem resistance, Mann
Whitney U test, Z =  3.787, p = 0.001 following correction). A
total of 13 isolates (16%) were resistant to tigecycline, and none
to colistin. A large proportion of isolates were found to carry
resistance genes, with 48 isolates (58%) carrying blaOXA 23 like
genes, 11 isolates (13%) carrying blaOXA 40 like genes, and 78
isolates (94%) carrying a blaVIM gene. PCRs for blaOXA 58 like,
blaIMP, blaNDM, blaSIM, and blaGIM genes were all negative. There
was a significant difference in the presence of blaOXA 40 genes
between the different PFGE groups (Kruskal Wallis, $2 = 25.12,
d.f. = 7, p = 0.003 following correction), with the gene
being detected with particularly high frequency in PFGE group
E (Figure 1). Phenotypic resistance to the carbapenems was
associated with the presence of a blaOXA 23 like gene rather
than the presence of a blaVIM like gene (meropenem resistance
vs blaOXA 23 like carriage: Mann Whitney U test, Z =  7.162,
p< 0.00001 following correction;meropenem resistance vs blaVIM
carriage: Mann Whitney U test, Z =  0.429, p = 0.713 following
correction).
A total of 65 isolates (78%) were positive by PCR for ISAba1,
while only two isolates were positive for ISAba2. The insertion
sequences ISAba3 and IS18were not detected. The different PFGE
groups differed significantly in the presence of ISAba1 (Kruskal
Wallis, $2 = 23.06, d.f. = 7, p = 0.004 following correction) with
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FIGURE 1 | Isolate relatedness, antibiotic resistances and molecular screening of isolates. In the ID column, DM stands for Diabetes Mellitus, NDM for
non-Diabetes Mellitus. IMIP, imipenem; MER, meropenem; TIG, tigecycline; COL, colistin. (A–H) Indicate PFGE groups assigned as described in the text.
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FIGURE 2 | Location of hospitals from where isolates were obtained, and (insert) the distribution of PFGE clones (as defined in Figure 1) by their
geographic location. Hospitals are shown as stars, and major roads as red lines.
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FIGURE 3 | Maximum likelihood phylogeny based upon amino-acid sequences of OXA-51-like enzymes. Enzymes that were encoded by isolates in the
present study are highlighted in red. The phylogeny is mid-point rooted, with support for the branches estimated from 100 bootstraps.
higher frequencies of detection of this element in PFGE groups A,
C, D, E, and H (Figure 1).
Sequencing of the blaOXA 51 like alleles identified the presence
of the blaOXA 66 allele in 54 isolates (65%), with the remaining 29
isolates encoding one of 15 otherOXA-51-like enzymes (Figures 1
and 3). Isolates carrying a blaOXA 66 allele were considered to
belong to the World-wide clone 2 (WW2) lineage (Evans et al.,
2008; Higgins et al., 2009). Isolates belonging to one of the PFGE
groupsweremore likely to encode a blaOXA 66 allele, while isolates
thatwere not groupedweremore likely to encode a non-blaOXA 66
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allele (Mann Whitney U test, Z =  2.981, p = 0.012 following
correction). In addition there was a significant difference in
the association of ISAba1 with blaOXA 51 like alleles, with the
insertion sequence found significantly more often upstream of
blaOXA 66 alleles than non-blaOXA 66 alleles (Mann Whitney U
test, Z =  3.171, p= 0.011 following correction).
Discussion
Carbapenem-resistant A. baumannii pose a significant challenge
to the treatment of infected patients. These patients are usually
immunocompromised, and the elimination of the carbapenem
antibiotics as an effective therapy leaves very few treatment
options open. In the current study, A. baumannii isolates from
hospitals in the Eastern District of Saudi Arabia were examined
to identify their mechanisms of resistance to the carbapenems
and their local epidemiology, both within the hospitals and the
District.
Typically, the isolation of many carbapenem-resistant bacteria
within a hospital may be explained by two epidemiological
patterns: the emergence and spread of a particularly successful
clone, or the persistence and co-existence of many clonal lineages,
potentially with importation from the community. Our data
are most consistent with the latter scenario for two reasons.
Firstly, many different PFGE groups were identified both within
Al Ahsa and Al Qatif. Moreover, isolates from the same PFGE
groups were identified in different hospitals. It is also noteworthy
that 25% of the isolates were not assigned to a PFGE group.
The distribution of isolates from the same PFGE group across
the Eastern District (Al Kafji and Al Ahsa are 430 km apart
by road, Figure 2) and the identification of many ungrouped
carbapenem-resistant isolates suggest the persistent co-existence
of many lineages across the region. Secondly, there is a large
degree of variation in antibiotic resistance phenotypes and
genotypes within PFGE groups. The only features that were
significantly associated with PFGE groups were the presence
of blaOXA 40 like genes, and the presence of ISAba1. However,
these genes were still identified in isolates belonging to PFGE
groups that were not significantly associated with their carriage.
Antibiotic resistance phenotypes and other genes associated
with resistance were distributed amongst PFGE groups and
ungrouped isolates, with no statistically significant positive or
negative association with any PFGE group. This suggests that
these genes are endemic within the general A. baumannii
population where they have either spread amongst the many
genetic lineages, or they have existed within the A. baumannii
population for a substantial period of time as the different genetic
lineages have diverged, with some genes being lost over time.
Taken together, these data are consistent with the endemicity of
a polyclonal carbapenem-resistant or carbapenemase-encoding
population of A. baumannii in the Eastern District of Saudi
Arabia.
Previous studies have identified carbapenem-resistant A.
baumannii isolates belonging to the WW2 lineage as being
widespread and responsible for outbreaks of infection in hospitals
globally (Higgins et al., 2009; Karah et al., 2012). In the current
study, the majority of isolates were considered to belong to WW2
by virtue of their specific blaOXA 51 like allele (Evans et al.,
2008; Higgins et al., 2009). A previous study associated isolates
carrying blaOXA 64 with multi-locus sequence typing (MLST)
clonal complex (CC) 25, blaOXA 51 with CC15, blaOXA 100 with
CC32, and blaOXA 65 with CC79 from the Pasteur MLST scheme
(Pournaras et al., 2014). As such, isolates identified in the present
study may also belong to these clonal complexes. Despite the
fact that many different PFGE groups were identified, isolates
belonging to one of these PFGE groups were statistically more
likely to belong toWW2 than the ungrouped isolates. In addition,
these WW2 isolates were statistically more likely to encode an
ISAba1 element upstream of the blaOXA 51 like genes, which has
been implicated in increased expression of the b-lactamase gene
(Turton et al., 2006). As has been identified previously (Evans
et al., 2008; Hamouda et al., 2010), PFGE profiles did not correlate
perfectly with the blaOXA 51 like gene content of the isolates in
a few cases, which may be explained by potential mobilization
of the blaOXA 51 like genes (Chen et al., 2010). Together these
data are consistent with previous studies, and demonstrate
that the different PFGE groups identified in this study are
subgroups of WW2, and therefore this global clone represents
the majority of carbapenem-resistant isolates in the Eastern
District.
The question arises as to the precise nature of the local
epidemiology of carbapenem resistance in these isolates. There are
two scenarios that can be explored. Firstly, a series of endemic
clones may be circulating within and amongst hospitals in the
Eastern District, with the transmission of plasmids carrying
antibiotic resistance determinants responsible for a large degree
of the variation in antibiotic resistance phenotype and genotype
between strains. Secondly, carbapenem-resistant A. baumannii
may be endemic within the community, with strains being
imported into the hospital where they briefly spread, before being
replaced by other strains. Most of the isolates (94%) in the current
study were collected between October 2010 and April 2011, and
as such an assessment cannot be made from these data of the
changes in frequency of different strains over time. Establishing
which of these scenarios reflect the situation in the Eastern
District will enable the appropriate infection control advice to
be given to hospitals to reduce the prevalence of carbapenem-
resistant A. baumannii, and is the subject of our future
research.
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